ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Autoinflammatory diseases"

  • Abstract Number: 0387 • ACR Convergence 2024

    Absolute Agreement and Inter-rater Reliability of a Web-based Standardized Scoring Tool for Magnetic Resonance Images from Children with Chronic Nonbacterial Osteomyelitis (CNO) Amongst Radiologists

    Farzana Nuruzzaman1, T. Shawn Sato2, Jennifer Stimec3, Ramesh S. Iyer4, Andrew Carbert5, Joel Paschke5, Lauren Potts6, Xiaoyue Zhang7, Walter Maksymowych8, Polly Ferguson9 and Yongdong (Dan) Zhao10, and CARRA CRMO Workgroup, 1Stony Brook Children's Hospital, Stony Brook, NY, 2University of Iowa, Iowa City, 3Hospital for Sick Children, Toronto, ON, Canada, 4Seattle Children's Hospital, Seattle, WA, 5CARE Arthritis, Edmonton, AB, Canada, 6Artist, Long Beach, CA, 7Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 8University of Alberta, Edmonton, AB, Canada, 9University of Iowa Carver College of Medicine, Iowa City, IA, 10University of Washington, Redmond, WA

    Background/Purpose: The web-based ChRonic nonbacterial Osteomyelitis Magnetic Resonance Imaging Scoring (CROMRIS) portal was developed to assess specific features of bone and soft tissue inflammation in…
  • Abstract Number: 0927 • ACR Convergence 2024

    Synovial Macrophage Heterogeneity and Dynamics in Steady Stateand Rheumatoid Arthritis Mouse Model Time Course

    Jessica Maciuch1, Yidan Wang2, Tyler Therron3, Harris Perlman1 and Deborah Winter4, 1Northwestern University, Chicago, IL, 2Northwestern University, Hanover Park, IL, 3Northwestern University, Chicago, 4Northwestern University, Skokie, IL

    Background/Purpose: Macrophages are vital contributors to both pro-inflammatory signaling and tissue repair processes involved in the pathogenesis and remission of Rheumatoid Arthritis (RA). Recent research…
  • Abstract Number: 1740 • ACR Convergence 2024

    Performance of Large Language Models in Rheumatology Board-Like Questions: Accuracy, Quality, and Safety

    Jaime Flores Gouyonnet1, Mariana Gonzalez-Trevino1, Cynthia Crowson1, Ryan Lennon1, Alain Sanchez-Rodriguez2, Gabriel Figueroa-Parra3, Elena Joerns4, Bradly Kimbrough5, Maria Cuellar-Gutierrez1, Erika Navarro-Mendoza1 and Ali Duarte-Garcia1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic College of Medicine and Science, Rochester, MN, 3Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4Mayo Clinic, Rochester, 5Mayo Clinic Rochester, Rochester, MN

    Background/Purpose: Large language models (LLMs) are increasingly becoming a common source of information for clinicians. We aimed to evaluate the accuracy, quality, and safety of…
  • Abstract Number: 2039 • ACR Convergence 2024

    Canakinumab Treatment in Patients with Familial Mediterranean Fever: A Tertiary Center Experience

    Ozkan Berke Simsek1, Ali Ayla2 and Serdal Ugurlu3, 1Istanbul University-Cerrahpasa, Istanbul, 2UTHealth Houston Division of Rheumatology, Houston, TX, 3Istanbul University-Cerrahpasa, Istanbul, Turkey

    Background/Purpose: Canakinumab is one of the most commonly used second-line agents in familial Mediterranean fever (FMF) after treatment failure or discontinuation of colchicine treatment. The…
  • Abstract Number: 2627 • ACR Convergence 2024

    Development and Validation of a Novel Score System to Guide Diagnostic Procedures in Children with Concerns of Chronic Nonbacterial Osteomyelitis

    Rajdeep Pooni1, Sarah Menashe2, Melissa Oliver3, Anja Schnabel4, Eveline Wu5, Zhaoyi Wang6, Claire Yang7, Achille Marino8, Cassyanne Aguiar9, Johnathan Akikusa10, Ummusen Kaya Akca11, Beverly Almeida12, Simone Appenzeller13, Ozge Basaran14, Matthew Basiaga15, David Cabral16, Martina Capponi17, nathan Donaldson18, Bugra Egeli19, Emily Fox20, Antonella insalaco21, Ramesh Iyer22, Annette Jansson23, Inna Kostik24, Mikhail Kostik25, Leonard Kovalick26, Katia Kozu27, Sivia Lapidus28, Tzielan Lee29, Aleksander Lenert30, Kamran Mahmood31, Edoardo Marrani32, Doaa Mosa33, Alexander Mushkin34, Farzana Nuruzzaman35, Karen Onel36, Manuela Pardeo21, Trang Pham22, Lauren Potts37, Athimalaipet Ramanan38, Angelo Ravelli39, Nathan Rogers18, Ian Muse40, Micol Romano41, natalie Roseenwasser22, T. Shawn Sato42, Gabriele Simonini43, jennifer Soep18, Sara Stern44, Alexander Theos45, Lori Tucker46, Leslie Vogel2, Shima Yasin30, Katerina Bouchalova47, Alison Hendry48, Kevin Cain49, Hermann Girschick50, Fatma Dedeoglu19, Christian Hedrich51, Ronald Laxer52, Polly Ferguson30, Seza Ozen53 and Yongdong Zhao54, 1Stanford University, Berkeley, CA, 2Seattle Children's Hospital, University of Washington School of Medicine, Seattle, WA, 3Riley Hospital for Children, Indiana University School of Medicine, Indianopolis, IN, 4Pediatric Rheumatology, Department of Pediatrics, University Hospital Carl Gustav Carus, Dresden, Germany, 5University of North Carolina School of Medicine, Chapel Hill, NC, 6University of Washington School of Medicine, Seattle, Seattle, WA, 7Seattle Children's Hospital, Seattle, 8ASST Gaetano Pini-CTO, Milan, Italy, Milan, Italy, 9Children's Hospital of The King's Daughters, Eastern Virginia Medical School, Norfolk, VA, 10Royal Children's Hospital, Melbourne, Australia, 11Hacettepe University, Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, Ankara, Turkey, 12Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom, 13Unicamp, Campinas, SP, Brazil, 14Hacettepe University, Ankara, Turkey, 15Mayo Clinic, Rochester, MN, 16BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 17Sapienza University, Rome, Italy, 18University of Colorado School of Medicine, Aurora, CO, 19Boston Children's Hospital, Boston, MA, 20Children's Mercy Hospital, Kansas City, MO, 21IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, 22University of Washington School of Medicine, Seattle, WA, 23Dr. von Hauner Children´s Hospital, Munich, Germany, 24Sanatorium for children Detskie Dyuny, Saint-Petersburg, Russia, 25Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia, 26The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27Instituto da Criança e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil, 28Hackensack University Medical Center, Montclair, NJ, 29Stanford University School of Medicine, Palo Alto, CA, 30Carver College of Medicine, University of Iowa Hospitals & Clinics, Iowa City, IA, 31Alder Hey Children's Hospital, Liverpool, United Kingdom, 32ERN ReCONNET center, Meyer Children's Hospital-IRCCS, Firenze, Italy, 33Mansoura University Hospital, Mansoura City, Egypt, 34Science-Research Institute of Phthisiopulmonology, Saint-Petersburg, Russia, 35Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 36HSS, New York, NY, 37Patient Research Partner, Long Beach, CA, 38Bristol Royal Hosp for Children, Bristol, United Kingdom, 39IRCCS Giannina Gaslini, Genoa, Italy, 40Seattle Children's Research institute, Seattle, WA, 41Behcet and Autoinflammatory Disease Center, Western University, London, ON, Canada, 42University of Iowa, Iowa City, 43Meyer Children Hospital IRCCS; NEUROFARBA Department, University of Florence, Florence, Italy, 44University of Utah, Salt Lake City, UT, 45Patient/parent partner, Washington DC, DC, 46BC Children's Hospital, Vancouver, BC, Canada, 47Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital, Olomouc, Czech Republic,48Division of Medicine Middlemore Hospital Counties Manukau District Health, Auckland, New Zealand, 49University of Washington, Seattle, WA, 50Vivantes Clinic Friedrichshain, Berlin, Germany, 51University of Liverpool, Liverpool, United Kingdom, 52SickKids, Toronto, ON, Canada, 53Department of Pediatrics, Hacettepe University, Ankara, Turkey, 54Seattle Children's Research institute, Seattle, WA

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is an autoinflammatory bone disease. The diagnosis of CNO is made by recognizing typical clinical and imaging presentation and excluding…
  • Abstract Number: 0398 • ACR Convergence 2024

    Validation of Patient-Reported Outcomes Measurement Information System® (PROMIS®) Pediatric Measures for Children with Chronic Nonbacterial Osteomyelitis Using the CHOIR Data

    Mary Eckert1, Eveline Wu2, Melissa Oliver3, Joshua Scheck4, Sivia Lapidus5, Ummusen Kaya Akca6, Shima Yasin7, Aleksander Lenert8, Sara Stern9, Antonella insalaco10, Manuela Pardeo10, Gabriele Simonini11, Edoardo Marrani12, Xing Wang13, Bin Huang14, Leonard Kovalick15, Natalie Rosenwasser16, Erin Balay-Dustrude17, Gabriel Casselman16, Liau Adriel18, Ava Klein18, Yurong Shao4, Claire Yang4, Molly Briggs4, Emily Deng4, Iris Hamilton4, Ethan Mueller16, Elise Machrone4, Paige Trunnel4, Doaa Mosa19, Lori Tucker20, Hermann Girschick21, Ronald Laxer22, Georgina Tiller23, Jonathan Akikusa24, Christian Hedrich25, Karen Onel26, Fatma Dedeoglu27, Marinka Twilt28, Seza Ozen29, Polly Ferguson30, Laura Schanberg31, Bryce Reeve32 and Yongdong (Dan) Zhao33, 1Seattle Children's, Mercer Island, WA, 2University of North Carolina School of Medicine, Chapel Hill, NC, 3Indiana University, Indianapolis, IN, 4Seattle Children's Hospital, Seattle, 5Hackensack University Medical Center, Montclair, NJ, 6Hacettepe University, Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, Ankara, Turkey, 7University of Iowa Carver College of Medicine, Abu Dhabi, United Arab Emirates, 8University of Iowa, Iowa City, IA, 9University of Utah, Salt Lake City, UT, 10IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, 11Meyer Children Hospital IRCCS; NEUROFARBA Department, University of Florence, Florence, Italy, 12University of Florence, Firenze, Florence, Italy, 13Biostatistics Epidemiology and Analytics in Research, Seattle Children’s Research Institute, Seattle, WA, 14Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cinciannati, OH, 15UNC Health Care, Durham, NC, 16Seattle Children's Hospital, Seattle, WA, 17University of Washington, Seattle, WA, 18Seattle Children’s Research Institute, University of Washington, Seattle, 19Mansoura University Hospital, Mansoura City, Egypt, 20BC Children's Hospital, Vancouver, BC, Canada, 21Vivantes Clinic Friedrichshain, Wuerzburg, Germany, 22SickKids, Toronto, ON, Canada, 23University of British Columbia - Vancouver, Vancouver, BC, Canada, 24Royal Children's Hospital, Parkville, Victoria, Australia, 25University of Liverpool, Liverpool, United Kingdom, 26HSS, New York, NY, 27Boston Children's Hospital, Boston, MA, 28Alberta Children's Hospital, Calgary, AB, Canada, 29Department of Pediatrics, Hacettepe University, Ankara, Turkey, 30University of Iowa Carver College of Medicine, Iowa City, IA, 31Duke University Medical Center, DURHAM, NC, 32Duke University School of Medicine, Durham, 33University of Washington, Redmond, WA

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is an autoinflammatory bone disease. It is critical to capture the child’s health-related quality of life impact using validated patient-reported…
  • Abstract Number: 0934 • ACR Convergence 2024

    Screening NLRP3 Drug Candidates in Clinical Development:Lessons from Existing and Emerging Technologies

    Isak Tengesdal1, Carlo Marchetti1, Tim L.Th. Jansen2, Marc Y. Donath3, Naomi Schlesinger4 and Charles Dinarello1, 1University of Colorado, Denver, CO, 21VieCuri Medisch Centrum, Venlo, Netherlands, 3University of Basel, Basel, Switzerland, 4University of Utah, Salt Lake City, UT

    Background/Purpose: NLRP3 is emerging as an attractive upstream target of the pathway to down-modulate rather than to completely neutralize IL-1ß levels in both acute and…
  • Abstract Number: 1766 • ACR Convergence 2024

    STAT2-Associated Type I Interferonopathy: A Masquerade of Infectious Susceptibility

    Conor Gruber1, Angelica Lee2, Sofija Buta2, Marta Martin Fernandez2, Veronique Houdouin3, Jean-Laurent Casanova4, Alice Hadchouel5, Jacinta Bustamante5 and Dusan Bogunovic2, 1Mount Sinai Hospital, New York, NY, 2Columbia University, New York, NY, 3Robert Debré Hospital, Paris, France, 4Rockefeller University, New York, NY, 5Hôpital Necker-Enfants Malades, Paris, France

    Background/Purpose: Type I IFN (IFN-I) signaling is a potent inflammatory pathway fundamental to antiviral immunity. In humans, loss of IFN-I activity underlies severe viral disease,…
  • Abstract Number: 2040 • ACR Convergence 2024

    Effective Management of Idiopathic Recurrent Pericarditis with Anakinra in Clinical Practice

    Martin Michaud1, Laurent Sailler2, Mélanie LEMEU3, Brice CASTEL4, Fabienne Vacheret5, Laurent Prudhomme6 and Grégory Pugnet7, 1Clinique Saint Exupery, Toulouse, France, 2CHU Toulouse, Toulouse, France, 3CH Albi, Albi, France, 4CH TARBES, Tarbes, France, 5CH Perpignan, Perpignan, France, 6CH Castres, Castres, France, 7Toulouse Rangueil University Hospital, Toulouse, France

    Background/Purpose: Idiopathic recurrent pericarditis (IRP) is a rare autoinflammatory syndrome marked by recurrent pericardial inflammation after an initial episode of acute pericarditis. Standard treatment involves…
  • Abstract Number: 2651 • ACR Convergence 2024

    Vasculitis Associated with VEXAS Syndrome

    Megan Sullivan1, Kambiz Kalantari2, Carolyn Mead-Harvey3, Yael Kusne4, Mrinal Patnaik2, Abhishek Mangaonkar2, Ronald Go2, Daniel Montes2, Kaaren Reichard2, Horatiu Olteanu2, Melanie Bois2, Alexander Hines2, Julio Sartori-Valinotti5, Kenneth Warrington2 and Matthew Koster2, 1Mayo Clinic Arizona, Scottsdale, AZ, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Scottsdale, AZ, 4Mayo Clinic, Phoenix, AZ, 5Mayo Clinic, Rohester, MN

    Background/Purpose: VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a recently defined clinical entity that causes hematologic and autoinflammatory symptoms. Since its initial description…
  • Abstract Number: 0400 • ACR Convergence 2024

    Osteoclastogenesis from Peripheral Blood Mononuclear Cells in Children with Chronic Nonbacterial Osteomyelitis Are Similar to Those from Healthy Children

    Jacqueline Bui1, Jacob Curry2, Jessica Kent3, Payton Danosky4, Kellen Sanders4, Sriya Paluvayi4, Wendy Garcia4, Alejandra Ruppe4, Megan Cheung4, Anna Saack4, Xinrui Bao4, Audrey Luey4, Michelle Kim4, Emily McDaniel4, Amanda Chiu4, Sophia Ahn5, Ji-Won Park4, Sudheshna Thirunahari4, Cammie Wei4, Liau Adriel5, Sophia Pham4, Sadie Van Den Bogaerde4, Joshua Scheck4, Ian Muse6, Ava Klein5, Xing Wang7, James Cassat8 and Yongdong Zhao6, 1Seattle Children’s Research Institute, University of Washington, Bellevue, WA, 2Seattle Children’s Research Institute, Vanderbilt University Medical Center, Seattle, WA, 3Seattle Children’s Research Institute, Medical College of Wisconsin, Seattle, WA, 4Seattle Children’s Research Institute, University of Washington, Seattle, WA, 5Seattle Children’s Research Institute, University of Washington, Seattle, 6Seattle Children's Research institute, Seattle, WA, 7Biostatistics Epidemiology and Analytics in Research, Seattle Children’s Research Institute, Seattle, WA, 8Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) is an autoinflammatory bone disease in which osteoclastogenesis may play a critical role. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) was shown…
  • Abstract Number: 0999 • ACR Convergence 2024

    Clinical and Biological Features of VEXAS Syndrome in Women: Study of 9 French Cases Compared with 263 Men

    Rim Bourguiba1, Valentin Lacombe2, Vincent Jachiet3, Thibault Comont4, Joris Galland5, Mael Heiblig6, Alexandre Nguyen7, Achille Aouba8, Xavier Boulu9, Alexandre Curie10, Pierre Sujobert11, Pierre Hirsch12, Olivier Kosmider13, Arsene Mekinian14 and Sophie Georgin-lavialle15, and French VEXAS study group, 1Hopital des Forces de sécurité de l'interieur, La Marsa, Tunisia, 2Angers University Hospital, Angers, France, 3Service de Médecine intene, Hopital Saint-Antoine, Paris France, Paris, France, 44 Service de médecine interne, Hopital Toulouse, France, Toulouse, France, 5Service de médecine interne, Centre hospitalier de Bourg- En-Bresse, France, Bourg en Bresse, France, 6Service de médecine interne, Centre Hospitalier Lyon Sud, Lyon, France, 7Service de médecine interne, CHU Cean, France, Cean, France, 8Service d'immunologie clinique-médecine interne, CHU de Caen Normandie, Caen, France, 98 Service de médecine interne, CHU Amiens Picardie, France, Amiens, France, 10Service de médecine interne, CH Eure Seine, France, Eure seine, France, 11Service d'hématologie, Centre Hospitalier Lyon Sud, France, Lyon, Tunisia, 12Hopital Saint-Antoine, Paris, France, Paris, France, 13Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris Cité, Cochin Hospital, Paris, France, Paris, France, 14Saint Antoine University Hospital, Paris, France, 15Sorbonne Université, Department of internal medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

    Background/Purpose: VEXAS syndrome is an autoinflammatory disease associated with somatic mutations in the UBA1 gene, which is located on the X chromosome, which explains the…
  • Abstract Number: 1773 • ACR Convergence 2024

    Divergent Genetic Architecture in Boys and Girls with NEMO-deleted Exon 5 Autoinflammatory Syndrome (NEMO-NDAS) Implies Role for Wildtype Effector Cells

    Adriana Almeida de Jesus1, Kip Friend2, Bin Lin3, Eric Karlins4, Colton McNinch4, Sara Alehashemi5, Keith Kauffman6, FARZANA BHUYAN3, Taylor Newbolt6, Andrea Bohrer7, Andre Rastegar3, Sophia Park3, Dana Kahle3, Jacob Mitchell3, Amanda Chen3, Sofia Torreggiani8, Kader Cetin Gedik9, Katsiaryna Uss2, Amer Khojah10, Eveline Wu11, Christiaan Scott12, Timothy Ronan Leahy13, Emma MacDermott14, Orla Killeen15, Thaschawee Arkachaisri16, Brian Nolan17, Zoran Gucev18, Kathryn Cook19, Vafa Mammadova20, Gulnara Nasrullayeva20, Mariana Correia Marques21, Abigail Bosk22, Seza Ozen23, Scott Canna24, Maude Tusseau25, Emilie Chopin26, Guilaine Boursier27, Veronique Hentgen28, Ines Elhani29, Mario Sestan30, Marija Jelusic31, Danielle Fink32, Douglas Kuhns32, Clifton Dalgard33, Alexandre Belot34, Timothy Moran11, Katherine Meyer-Barber7, Andrew Oler4, Daniel Barber6 and Raphaela Goldbach-Mansky35, 1NIAID, NIH, Silver Spring, MD, 2Translational Autoinflammatory Diseases section (TADS), LCIM, NIAID, NIH, Bethesda, MD, 3TADS, NIAID, NIH, Bethesda, MD, 4BCBB, NIAID, NIH, Bethesda, MD, 5NIH/NIAID/TADS, Potomac, MD, 6T Lymphocyte Biology Section, LPD, NIAID, NIH, Bethesda, MD, 7Inflammation and Innate Immunity Unit, LCIM, NIAID, NIH, Bethesda, MD, 8University Of Maryland Baltimore, Baltimore, MD, 9Translational Autoinflammatory Diseases section (TADS), LCIM, NIAID, NIH, Pittsburgh, PA, 10Umm Al-Qura University, Makkah, Saudi Arabia, 11University of North Carolina School of Medicine, Chapel Hill, NC, 12University of Cape Town, Cape Town, South Africa, 13Children’s Health Ireland (CHI) at Crumlin, Dublin, Ireland, 14CHI Crumlin, Dublin, Dublin, Ireland, 15Children's Health Ireland, Dublin, Ireland, 16KK Women's and Children's Hospital, SingHealth, Singapore, Singapore, 17Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, 18University Children's Hospital, Skopje, Macedonia, 19Akron Children's Hospital, Akron, OH, 20Azerbaijan Medical University, Baku, Azerbaijan, 21National Institutes of Health, Bethesda, MD, 22Children's National Hospital, Bethesda, DC, 23Department of Pediatrics, Hacettepe University, Ankara, Turkey, 24Children's Hospital of Philadelphia, Philadelphia, PA, 25RAISE, Hospices Civils de Lyon, Lyon, France, 26Hospices Civils de Lyon, Lyon, France, 27University of Montpellier, Montpellier, 28Laboratoire de Génétique des Maladies Rares et Autoinflammatoires, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, CEREMAIA, CHU de Montpellier, Univ Montpellier, Montpellier, France, Le Chesnay, France, 29Department of Internal Medicine, Caen University Hospital, Caen, France, Caen, France, 30University of Zagreb School of Medicine University Hospital Centre Zagreb, Zagreb, Croatia, 31University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Zagreb, Croatia, 32Collaborative Clinical Research Branch, NIAID, NIH, Bethesda, MD, Bethesda, MD, 33The American Genome Center, Department of Anatomy, Physiology & Genetics, Uniformed Services University, Bethesda, MD, 34Hospices Civils de Lyon, Collonges au mont d'or, France, 35Translational Autoinflammatory Diseases section (TADS), LCIM, NIAID, NIH, Potomac, MD

    Background/Purpose: Splice-site variants in X-linked IKBKG cause NEMO-deleted exon5 autoinflammatory syndrome (NEMO-NDAS); a pseudogene (IKBKGP1) complicates genetic diagnosis. NEMO-NDAS is four times more common in…
  • Abstract Number: 2044 • ACR Convergence 2024

    Clinical Practice Patterns, Rilonacept Appropriate Use for Recurrent Pericarditis

    Jessica Farrell1, Michael Allen2, Lee Shapiro3, Victoria Michaels4, Arifa Javed5, Nabiha Qureshi6, Summia Matin Afridi7, Shahad Almahmoud8, Getzabeth Bosques Gomez9 and Khoa Richard Ngo10, 1Albany College of Pharmacy & Health Sciences/Albany Medical Center, Delmar, NY, 2Albany Medical Center, Delmar, NY, 3Albany Medical College, Stillwater, NY, 4Albany Medical Center, Wynantskill, NY, 5Albany Medical Center, Rensselaer, NY, 6Albany Medical Center, Menands, NY, 7Albany Medical Center, Albany, NY, 8Albany College of Pharmacy & Health Sciences/Albany Medical Center, Albany, NY, 9Albany College of Pharmacy and Health Sciences/Albany Medical Center, Albany, NY, 10Albany Medical Center, Voorheesville, NY

    Background/Purpose: Pericarditis is inflammation of the pericardial sac which can be of infectious or non-infectious etiology, commonly associated with rheumatic diseases. Pericarditis is defined as…
  • Abstract Number: 2659 • ACR Convergence 2024

    A Comprehensive Approach Utilizing a Combination of Genetics, Cytological Analysis, and Imaging Techniques to Speed up the Diagnostic Process in VEXAS Patients

    Sara Bindoli1, Chiara Baggio2, Roberto Padoan3, Riccardo Bixio4, doria Andrea5, Roberta Ramonda2 and Paolo Sfriso1, 1Rheumatology Unit, University of Padova, Italy, Padova, Veneto, Italy, 2Rheumatology Unit, University of Padova, Italy, Padova, Italy, 3Department of Medicine DIMED, Division of Rheumatology, University of Padua, Padua, Italy, 4University of Verona, Verona, Verona, Italy, 5University of Padova, Padova, Italy

    Background/Purpose: VEXAS is a newly described “haemato-autoinflammatory” condition resulting from somatic mutations in the UBA-1 gene. By integrating genetics, cytology and imaging, this work seeks…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 20
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology